Sectra

TriMed Staff | | Health Imaging | Screening
Sectra (Booth 9124) is featuring the capabilities and functionality of its Sectra MicroDose Mammography, L30 full-field digital mammography (FFDM) platform, and is premiering an integrated mammography screening solution.

The firm also is showcasing the new generation of its photon-counting FFDM system, Sectra MicroDose Mammography, L30, currently the only commercially available photon-counting mammography system on the market, according to Sectra. It is available for sale outside of the U.S. Photon-counting is a technology for better images, lower dose and fundamental advantages in several advanced applications, such as contrast mammography, dual-energy and tomosynthesis.

The company also is demonstrating an integrated solution for mammography screening, including Sectra Screening RIS, Sectra MicroDose Mammography and Sectra Breast Imaging PACS, all designed to efficiently streamline mammography workflow.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.